CDC HICPAC Guidelines for Environmental Infection Control — Pest Control Recommendations

Source Record
Authority Type
Federal Regulator
Citation
CDC HICPAC Guidelines for Environmental Infection Control in Health-Care Facilities (2003), Part II, Section E.V.
Primary Source
https://www.cdc.gov/infection-control/hcp/environmental-control/recommendations.html
Source Tier
Tier 1
Confidence
HIGH
Paywalled
No
Verbatim Available
Yes
Last Verified
May 25, 2026
Verified by Trenton L. Frazer, BCE #B3413 · Board Certified Entomologist · verification methodology

Citation

CDC Healthcare Infection Control Practices Advisory Committee (HICPAC), Guidelines for Environmental Infection Control in Health-Care Facilities (2003). Originally published in MMWR Recomm Rep 2003;52(RR-10):1-42. Part II — Recommendations, Section E.V. Pest Control. The 2003 guidelines remain the current active recommendations as of 2026.

What It Says (Verbatim)

Section E.V. contains exactly four recommendations on pest control in healthcare facilities:

E.V.1 (Category II):

“Develop pest-control strategies, with emphasis on kitchens, cafeterias, laundries, central sterile-supply areas, operating rooms, loading docks, construction activities, and other areas prone to infestations.”

E.V.2 (Category IB):

“Install screens on all windows that open to the outside; keep screens in good repair.”

E.V.3 (Category II):

“Contract for routine pest control service by a credentialed pest-control specialist who will tailor the application to the needs of a health-care facility.”

E.V.4 (Category II):

“Place laboratory specimens (e.g., fixed sputum smears) in covered containers for disposal.”

HICPAC Category Definitions

The recommendation categories carry specific evidentiary weight under HICPAC’s published rating system:

Category IA: Strongly recommended for implementation and strongly supported by well-designed experimental, clinical, or epidemiologic studies.

Category IB: Strongly recommended for implementation and supported by some experimental, clinical, or epidemiologic studies and a strong theoretical rationale.

Category IC: Required for implementation, as mandated by federal or state regulation or standard.

Category II: Suggested for implementation and supported by suggestive clinical or epidemiologic studies, or a theoretical rationale.

Unresolved Issue: Practices for which insufficient evidence or no consensus regarding efficacy exists.

E.V.2 (window screening) is Category IB. E.V.1, E.V.3, and E.V.4 are Category II.

What It Means in Plain Language

HICPAC E.V. is the most-cited federal authority on pest control in U.S. healthcare facilities. It establishes four foundational expectations: a documented pest-control strategy with named high-risk areas, physical exclusion through window screening, contracted pest control performed by a credentialed specialist tailoring the program to healthcare-specific needs, and proper containment of laboratory specimens.

The verbatim language at E.V.3 is the operative anchor for credentialing arguments in healthcare pest contracting. The phrase “credentialed pest-control specialist who will tailor the application to the needs of a health-care facility” appears in CDC’s primary recommendation document. The word “credentialed” is intentionally undefined — leaving facilities to determine which credential satisfies the call. The universe of recognized credentials in U.S. pest management includes (in ascending order of rigor): state pesticide applicator licensure, the ESACC Associate Certified Entomologist (ACE), the ESACC Public Health Entomology certificate (PHE), the ESACC Certified IPM Technician (CIT), the ESACC Board Certified Entomologist (BCE), and the NPMA QualityPro company-level accreditation.

Among these, the Board Certified Entomologist credential carries the highest evidentiary weight as the answer to HICPAC’s call. BCE is the only credential that requires a bachelor’s-level (or higher) degree in biological or life sciences, formal post-degree field experience, two examinations including a defined specialty, ongoing 120 continuing education units per three-year reporting period, and adherence to a Code of Ethics enforceable by certification revocation.

Who It Applies To

CDC HICPAC guidelines are not regulations and are not directly enforceable. They function as the standard of care reference cited by accrediting bodies (The Joint Commission, DNV-GL, HFAP, CIHQ), infection prevention professionals, state survey agencies, plaintiff and defense attorneys in healthcare litigation, and risk management consultants. They apply by reference to all U.S. healthcare facilities providing patient care.

The Joint Commission’s Infection Prevention and Control standards explicitly reference HICPAC guidelines as a primary source. CMS State Operations Manual references HICPAC guidelines in interpretive guidance for §482.42 (Infection Prevention and Control Conditions of Participation). State health departments and accrediting bodies use HICPAC as the de facto national standard of care for environmental infection control.

Documentation Evidence Required

Compliance with HICPAC E.V. is typically demonstrated through:

How Surveyors Evaluate It

Joint Commission surveyors, CMS validation surveyors, and DNV-GL surveyors reference HICPAC guidelines when evaluating environmental infection control programs. Surveyors specifically look for:

Common surveyor findings under HICPAC reference include: missing high-risk area coverage in the written plan, deteriorated window screens, generic commercial pest control programs not tailored to healthcare needs, and use of uncredentialed applicators where the contract calls for credentialed service.

Confidence Notes

HIGH confidence. Section E.V. verbatim text reproduced from CDC’s primary source publication. Category ratings verified against CDC’s published rating system. The 2003 guidelines remain CDC’s current active recommendations on environmental infection control as of the verification date. CDC has not issued a substantive update to the environmental infection control guidelines since 2003.

The following adjacent claims have been investigated and disconfirmed: